For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Procept BioRobotics Corp (NASDAQ: PRCT) closed at $52.48 in the last session, down -2.36% from day before closing price of $53.75. In other words, the price has decreased by -$2.36 from its previous closing price. On the day, 0.52 million shares were traded. PRCT stock price reached its highest trading level at $54.79 during the session, while it also had its lowest trading level at $51.95.
Ratios:
We take a closer look at PRCT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.77 and its Current Ratio is at 7.63. In the meantime, Its Debt-to-Equity ratio is 0.28 whereas as Long-Term Debt/Eq ratio is at 0.28.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on August 11, 2023, initiated with a Overweight rating and assigned the stock a target price of $42.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 18 ’24 when Zadno Reza sold 5,391 shares for $48.83 per share. The transaction valued at 263,243 led to the insider holds 241,319 shares of the business.
Waters Kevin sold 1,024 shares of PRCT for $50,002 on Mar 18 ’24. The EVP, CFO now owns 102,149 shares after completing the transaction at $48.83 per share. On Mar 18 ’24, another insider, Nouri Alaleh, who serves as the EVP, CLO, CORP. SEC. of the company, sold 441 shares for $48.83 each. As a result, the insider received 21,534 and left with 62,472 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRCT now has a Market Capitalization of 2697482496 and an Enterprise Value of 2498469888. For the stock, the TTM Price-to-Sale (P/S) ratio is 19.64 while its Price-to-Book (P/B) ratio in mrq is 9.49. Its current Enterprise Value per Revenue stands at 18.345 whereas that against EBITDA is -23.713.
Stock Price History:
Over the past 52 weeks, PRCT has reached a high of $54.50, while it has fallen to a 52-week low of $24.83. The 50-Day Moving Average of the stock is 6.68%, while the 200-Day Moving Average is calculated to be 32.83%.
Shares Statistics:
According to the various share statistics, PRCT traded on average about 477.58K shares per day over the past 3-months and 564350 shares per day over the past 10 days. A total of 50.77M shares are outstanding, with a floating share count of 48.57M. Insiders hold about 4.69% of the company’s shares, while institutions hold 88.89% stake in the company. Shares short for PRCT as of 1711584000 were 4648490 with a Short Ratio of 9.73, compared to 1709164800 on 4516005. Therefore, it implies a Short% of Shares Outstanding of 4648490 and a Short% of Float of 12.34.
